BIIE0246:: A selective and high affinity neuropeptide YY2 receptor antagonist

被引:168
作者
Doods, H [1 ]
Gaida, W [1 ]
Wieland, HA [1 ]
Dollinger, H [1 ]
Schnorrenberg, G [1 ]
Esser, F [1 ]
Engel, W [1 ]
Eberlein, W [1 ]
Rudolf, K [1 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany
关键词
neuropeptide Y; neuropeptide YY2; receptor antagonist; BIIE0246;
D O I
10.1016/S0014-2999(99)00650-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in vitro biological characterisation of the first potent and selective non-peptide neuropeptide Y Y-2 receptor antagonist, (S)-N-2-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6h)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl] cylopentyl] acetyl-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamid (BIIE0246) is reported. BIIE0246 displaced [I-125]neuropeptide Y with high affinity (IC50 = 3.3 nM) from the human neuropeptide Y Y-2 receptor and proved to be highly selective. BIIE0246 displayed antagonistic properties and thus represents the first selective non-peptide neuropeptide Y Y-2 receptor antagonist. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:R3 / R5
页数:3
相关论文
共 8 条
[1]   Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor [J].
Criscione, L ;
Rigollier, P ;
Batzl-Hartmann, C ;
Rüeger, H ;
Stricker-Krongrad, A ;
Wyss, P ;
Brunner, L ;
Whitebread, S ;
Yamaguchi, Y ;
Gerald, C ;
Heurich, RO ;
Walker, MW ;
Chiesi, M ;
Schilling, W ;
Hofbauer, KG ;
Levens, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2136-2145
[2]   DIFFERENT NEUROPEPTIDE-Y RECEPTOR SUBTYPES IN RAT AND RABBIT VAS-DEFERENS [J].
DOODS, HN ;
KRAUSE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) :101-103
[3]   EXPRESSION CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HIPPOCAMPAL NEUROPEPTIDE-Y PEPTIDE YY Y2 RECEPTOR SUBTYPE [J].
GERALD, C ;
WALKER, MW ;
VAYSSE, PJJ ;
HE, CG ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26758-26761
[4]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[5]   Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor - Synthesis and pharmacological evaluation of a Y2 antagonist [J].
Grouzmann, E ;
Buclin, T ;
Martire, M ;
Cannizzaro, C ;
Dorner, B ;
Razaname, A ;
Mutter, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :7699-7706
[6]  
Michel MC, 1998, PHARMACOL REV, V50, P143
[7]   THE FIRST HIGHLY POTENT AND SELECTIVE NONPEPTIDE NEUROPEPTIDE-Y Y-1-RECEPTOR ANTAGONIST - BIBP3226 [J].
RUDOLF, K ;
EBERLEIN, W ;
ENGEL, W ;
WIELAND, HA ;
WILLIM, KD ;
ENTZEROTH, M ;
WIENEN, W ;
BECKSICKINGER, AG ;
DOODS, HN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (2-3) :R11-R13
[8]   Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents [J].
Wieland, HA ;
Engel, W ;
Eberlein, W ;
Rudolf, K ;
Doods, HN .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (03) :549-555